can tirzepatide cause bowel obstruction Severe Small-Bowel in a High-Risk Patient on Long-Term Therapy: A Case Report What is the recommended management

These include: Bloating and gas : Increased bacterial fermentation produces gases, causing abdominal distension and flatulence Mild abdominal discomfort or cramping : Usually resolves as the microbiome stabilises Changes in bowel habits : Temporary loose stools or, less commonly, constipation Nausea : Occasionally reported, particularly if taken on an empty stomach These symptoms typically diminish within 23 weeks of consistent use

Those who received the semaglutide lost close to 15 percent of their body weight, on average, compared to 2.4 percent among those receiving the placebo

Compounded oral tirzepatide is not an FDA-approved drug, and it is not the same as any branded product

Healthcare providers should proactively adjust these medications, and patients should monitor blood glucose regularly during the titration phase

Semaglutide users experienced a 1.7% drop in HbA1c, while the liraglutide group showed a 1.0% reduction